Today, biospecimen collections are used by multiple groups for various aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research.
The proper collection, processing, storage, and tracking of biospecimens are vital components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. With an eye to the value of precious clinical biosamples, Cambridge Healthtech Institute’s fourth annual Leaders in Biobanking Congress addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best tactics for effective use of biospecimens within today’s cutting edge research.
Visit for more details